AVIR
NASDAQ · Pharmaceuticals
Atea Pharmaceuticals Inc
$5.39
+0.06 (+1.13%)
Open$5.37
Previous Close$5.33
Day High$5.51
Day Low$5.35
52W High$42.64
52W Low$24.62
Volume—
Avg Volume593.3K
Market Cap324.23M
P/E Ratio—
EPS$-1.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+754.4% upside
Current
$5.39
$5.39
Target
$46.05
$46.05
$31.54
$46.05 avg
$64.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 49.99M | 49.26M | 44.69M |
| Net Income | 8.60M | 11.50M | 7.45M |
| Profit Margin | 17.2% | 23.3% | 16.7% |
| EBITDA | 12.90M | 12.92M | 13.20M |
| Free Cash Flow | 9.03M | 8.66M | 6.93M |
| Rev Growth | +19.5% | +7.9% | +2.0% |
| Debt/Equity | 0.36 | 0.36 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |